Journal Information
Vol. 43. Issue S3.
Pages S50 (November 2021)
Share
Share
Download PDF
More article options
Vol. 43. Issue S3.
Pages S50 (November 2021)
OTHER DISEASESPP 46
Open Access
DOES BLOOD TYPE HAVE AN EFFECT ON THE COURSE OF COVID-19?
Visits
1347
Fatma YILMAZ1, Murat ALBAYRAK1, Abdülkerim YILDIZ2, Hacer Berna AFACAN ÖZTÜRK1, Senem MARAL1, Pınar AKYOL1, Merih REİS ARAS1, Buğra SAĞLAM1, Mesut TIĞLIOĞLU1
1 University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Department of Hematology
2 University of Hitit,Erol Olçok Training and Research Hospital, Department of Hematology
This item has received

Under a Creative Commons license
Article information
Special issue
This article is part of special issue:
Vol. 43. Issue S3
More info
Objective

Predictive parameters that can affect the course of this infection have been the main topic of research since the beginning of the COVID-19 (Coronavirus disease 2019) pandemic. Since the discovery of blood groups, the effect of these on infectious diseases has always been of interest

Methodology

To analyze the effect of ABO blood group on mortality, hospitalization duration and  hematological and cytokine storm parameters in patients with COVID-19. This retrospective study was conducted on 140 patients diagnosed with COVID-19. Demographic characteristics, laboratory parameters including ABO blood group, complete blood count (CBC) parameters, biochemical tests, cytokine storm parameters, duration of hospitalization, and final status (discharge or death) were recorded.

Results

The 140 patients included in the analysis comprised 72 (51.4%) males and 68 (48.6%) females with a mean age of 66.3±14.0 years. . Age and gender, hospitalization duration and mortality rates were similar in all blood group types. Only D-dimer values were found to be higher in blood group A compared with other blood groups.

Conclusion

Although no difference in mortality was determined between groups,  the D-dimer level was statistically significantly higher in COVID-19 patients with A blood group.  Larger studies are needed to reflect D-dimer levels on the clinical course of infection, and thus on daily practice

Full text is only aviable in PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Article options
Tools